The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors
Open accessAbstract
Significance Understanding of myelin diseases and development of new treatment options are at least partly hampered by the limited availability of human oligodendrocytes. Induced pluripotent stem cells (iPSC) may be an ideal tool to circumvent this problem; however, rapid and efficient protocols to generate oligodendrocytes from human iPSC are currently lacking. The induction of the transcription factors SOX10, OLIG2, and NKX6.2 in iPSC-derived neural progenitors accelerates oligodendroglial differentiation significantly resulting in up to 70% of O4 + oligodendrocytes within 28 d. These oligodendrocytes myelinate the CNS during development and after demyelination, and are suitable for pharmacological screens and disease modeling. The strategy presented herein will markedly facilitate the studying of human myelin diseases and the development of screening platforms for drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Somatic sources, such as fibroblasts or peripheral blood cells, can be reprogrammed into iPS cells or directly converted into neural lineages, offering versatile platforms to model MS, PMD and other neuroinflammatory or demyelinating disorders48–55.”
From From insights to innovations: evaluating preclinical paradigms in demyelinating disease therapeutics (2026) · cites this paper as [50]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Oligodendrocytes were derived from iPSCs as previously described [17].”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Lu, Q. R., Yuk, D.-I., Alberta, J., Zhu, Z.-M., Pawlitzky, I., Chan, J., McMahon, A., Stiles, C., & Rowitch, D. H. (2000) · Neuron · doi:10.1016/s0896-6273(00)80897-1 · Cited by 883
Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette
Sommer, C. A., Stadtfeld, M., Murphy, G. J., Hochedlinger, K., Kotton, D. N., & Mostoslavsky, G. (2009) · Stem Cells · doi:10.1634/stemcells.2008-1075 · Cited by 676
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis
Mei, F., Fancy, S. P. J., Shen, Y. A., Niu, J., Zhao, C., Presley, B., Miao, E., Lee, S., Mayoral, S. R., Redmond, S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3618 · Cited by 595
Wang, S., Bates, J., Li, X., Schanz, S., Chandler-Militello, D., Levine, C., Maherali, N., Studer, L., Hochedlinger, K., Windrem, M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.002 · Cited by 586
A regenerative approach to the treatment of multiple sclerosis
Deshmukh, V. A., Tardif, V., Lyssiotis, C. A., Green, C. C., Kerman, B., Kim, H. J., Padmanabhan, K., Swoboda, J. G., Ahmad, I., Kondo, T., et al. (2013) · Nature · doi:10.1038/nature12647 · Cited by 531
Reinhardt, P., Glatza, M., Hemmer, K., Tsytsyura, Y., Thiel, C. S., Höing, S., Moritz, S., Parga, J. A., Wagner, L., Bruder, J. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059252 · Cited by 461
Self-citationGhetti, B. F., Oblak, A. L., Boeve, B. F., Johnson, K. A., Dickerson, B. C., & Goedert, M. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12213 · Cited by 458
A culture system to study oligodendrocyte myelination processes using engineered nanofibers
Lee, S., Leach, M. K., Redmond, S., Chong, S. Y. C., Mellon, S. H., Tuck, S. J., Feng, Z. Q., Corey, J. M., & Chan, J. R. (2012) · Nature Methods · doi:10.1038/nmeth.2105 · Cited by 455
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo
Najm, F. J., Madhavan, M., Zaremba, A., Shick, E., Karl, R. T., Factor, D. C., Miller, T. E., Nevin, Z. S., Kantor, C., Sargent, A., et al. (2015) · Nature · doi:10.1038/nature14335 · Cited by 424
Cited by
Sorted by citations
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes‐Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 799
Oligodendrocytes in development, myelin generation and beyond
Kuhn, S., Gritti, L., Crooks, D., & Dombrowski, Y. (2019) · Cells · doi:10.3390/cells8111424 · Cited by 625
Modeling Alzheimer’s disease with iPSC-derived brain cells
Penney, J., Ralvenius, W. T., & Tsai, L.-H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0468-3 · Cited by 471
In vitro Models of Neurodegenerative Diseases
Slanzi, A., Iannoto, G., Rossi, B., Zenaro, E., & Constantin, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00328 · Cited by 313
Fard, M. K., van der Meer, F., Sánchez, P., Cantuti-Castelvetri, L., Mandad, S., Jäkel, S., Fornasiero, E. F., Schmitt, S., Ehrlich, M., Starost, L., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7816 · Cited by 249
“To extend the analysis to human cells, we generated oligodendrocytes from induced pluripotent human stem cells (iPSCs) derived from healthy human adults (29).”
BackgroundSelf-citationA comprehensive library of human transcription factors for cell fate engineering
Ng, A. H. M., Khoshakhlagh, P., Arias, J. E. R., Pasquini, G., Wang, K., Swiersy, A., Shipman, S. L., Appleton, E., Kiaee, K., Kohman, R. E., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0742-6 · Cited by 243
Renner, H., Grabos, M., Becker, K., Kagermeier, T., Wu, J., Otto, M., Peischard, S., Zeuschner, D., Tsytsyura, Y., Disse, P., et al. (2020) · eLife · doi:10.7554/elife.52904 · Cited by 229
Self-citationAdvancing cell therapy for neurodegenerative diseases
Temple, S. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.03.017 · Cited by 221
You, Y., Muraoka, S., Jedrychowski, M. P., Hu, J., McQuade, A., Young‐Pearse, T. L., Aslebagh, R., Shaffer, S. A., Gygi, S. P., Blurton-Jones, M. M., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12183 · Cited by 165
Li, L., Tian, E., Chen, X., Chao, J., Klein, J. A., Qu, Q., Sun, G., Sun, G., Huang, Y., Warden, C., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.07.009 · Cited by 139
Self-citationLesion stage-dependent causes for impaired remyelination in MS
Heß, K., Starost, L. J., Kieran, N. W., Thomas, C., Vincenten, M. C. J., Antel, J. P., Martino, G., Huitinga, I., Healy, L. M., & Kuhlmann, T. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02189-9 · Cited by 144
Self-citationRecent progress in translational engineered in vitro models of the central nervous system
Nikolakopoulou, P., Rauti, R., Voulgaris, D., Shlomy, I., Maoz, B. M., & Herland, A. (2020) · Brain · doi:10.1093/brain/awaa268 · Cited by 133
García‐León, J. A., Kumar, M., Boon, R., Chau, D., One, J., Wolfs, E., Eggermont, K., Berckmans, P., Gunhanlar, N., de Vrij, F. M. S., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.12.014 · Cited by 123
Autologous Induced Pluripotent Stem Cell–Based Cell Therapies: Promise, Progress, and Challenges
Madrid, M., Sumen, C., Aivio, S., & Saklayen, N. (2021) · Current Protocols · doi:10.1002/cpz1.88 · Cited by 121
The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury
Duncan, G. J., Manesh, S. B., Hilton, B. J., Assinck, P., Plemel, J. R., & Tetzlaff, W. (2019) · Glia · doi:10.1002/glia.23706 · Cited by 119
Tepavčević, V., & Lubetzki, C. (2022) · Brain · doi:10.1093/brain/awac307 · Cited by 115
Graphene-Based Scaffolds for Regenerative Medicine
Bellet, P., Gasparotto, M., Pressi, S., Fortunato, A., Scapin, G., Mba, M., Menna, E., & Filippini, F. (2021) · Nanomaterials · doi:10.3390/nano11020404 · Cited by 116
Barák, M., Fedorová, V., Pospíšilová, V., Raška, J., Vochyánová, S., Sedmík, J., Hříbková, H., Klímová, H., Váňová, T., & Bohačiaková, D. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10254-3 · Cited by 102
Chamling, X., Kallman, A., Fang, W., Berlinicke, C. A., Mertz, J. L., Devkota, P., Pantoja, I. E. M., Smith, M. D., Ji, Z., Chang, C. K. W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-20892-3 · Cited by 103
Li, L., Chao, J., & Shi, Y. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2713-x · Cited by 89
Weider, M., Starost, L. J., Groll, K., Küspert, M., Sock, E., Wedel, M., Fröb, F., Schmitt, C., Baroti, T., Hartwig, A. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03336-3 · Cited by 92
Self-citationStarost, L., Lindner, M., Herold, M., Xu, Y. K. T., Drexler, H. C. A., Heß, K., Ehrlich, M., Ottoboni, L., Ruffini, F., Stehling, M., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02217-8 · Cited by 79
Self-citationAntidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain Model
Zhong, X., Harris, G., Smirnova, L., Zufferey, V., Sá, R. D. C. D. S. E., Russo, F. B., Braga, P. C. B. B., Chesnut, M., Zurich, M., Högberg, H. T., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00025 · Cited by 81
Mechanisms of axonal support by oligodendrocyte-derived extracellular vesicles
Krämer‐Albers, E., & Werner, H. B. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00711-y · Cited by 83
Raabe, F. J., Slapakova, L., Rossner, M. J., Cantuti‐Castelvetri, L., Simons, M., Falkai, P., & Schmitt, A. (2019) · Cells · doi:10.3390/cells8121496 · Cited by 80
Dissecting the complexities of Alzheimer disease with in vitro models of the human brain
Blanchard, J., Victor, M. B., & Tsai, L. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00578-6 · Cited by 68
Nie, L., Yao, D., Chen, S., Wang, J., Pan, C., Wu, D., Liu, N., & Tang, Z. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01532-9 · Cited by 69
Stem cell derived oligodendrocytes to study myelin diseases
Chanoumidou, K., Mozafari, S., Baron‐Van Evercooren, A., & Kuhlmann, T. (2020) · Glia · doi:10.1002/glia.23733 · Cited by 62
Self-citationHuman Glial Progenitor Cells Effectively Remyelinate the Demyelinated Adult Brain
Windrem, M. S., Schanz, S. J., Zou, L., Chandler-Militello, D., Kuypers, N. J., Nedergaard, M., Lu, Y. Q., Mariani, J. N., & Goldman, S. A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107658 · Cited by 60
Rajani, R. M., Ellingford, R., Hellmuth, M., Harris, S. S., Taso, O. S., Graykowski, D., Lam, F. K. W., Arber, C., Fertan, E., Danial, J. S. H., et al. (2024) · PLOS Biology · doi:10.1371/journal.pbio.3002727 · Cited by 62
“To determine this, we differentiated oligodendrocytes from human induced pluripotent stem cells (iPSCs) following a previously established protocol [17].”
BackgroundMethodResultInfluentialNext‐generation disease modeling with direct conversion: a new path to old neurons
Traxler, L., Edenhofer, F., & Mertens, J. (2019) · FEBS Letters · doi:10.1002/1873-3468.13678 · Cited by 57
Transcription Factor-Based Fate Specification and Forward Programming for Neural Regeneration
Flitsch, L. J., Laupman, K. E., & Brüstle, O. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00121 · Cited by 58
3D hydrogel models of the neurovascular unit to investigate blood–brain barrier dysfunction
Potjewyd, G., Kellett, K. A. B., & Hooper, N. M. (2021) · Neuronal Signaling · doi:10.1042/ns20210027 · Cited by 53
Massively parallel techniques for cataloguing the regulome of the human brain
Townsley, K. G., Brennand, K., & Huckins, L. M. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-00740-1 · Cited by 52
Cho, A., Jin, Y., Kim, S., Kumar, S., Shin, H., Kang, H., & Cho, S. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b03242 · Cited by 51
Fritsche, E., Barenys, M., Klose, J., Masjosthusmann, S., Nimtz, L., Schmuck, M. R., Wuttke, S., & Tigges, J. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy178 · Cited by 49
Modeling the complex genetic architectures of brain disease
Fernando, M. B., Ahfeldt, T., & Brennand, K. (2020) · Nature Genetics · doi:10.1038/s41588-020-0596-3 · Cited by 48
Berry, B. J., Smith, A. S. T., Young, J. E., & Mack, D. L. (2018) · Cells Tissues Organs · doi:10.1159/000493018 · Cited by 47
García-León, J., García-Díaz, B., Eggermont, K., Cáceres-Palomo, L., Neyrinck, K., da Costa, R. F. M., Davila, J., Evercooren, A. B.-V., Gutierrez, A., & Verfaillie, C. (2020) · Nature Protocols · doi:10.1038/s41596-020-0395-4 · Cited by 44
Mozafari, S., Starost, L., Manot-Saillet, B., Garcia-Diaz, B., Xu, Y. K. T., Roussel, D., Levy, M. J. F., Ottoboni, L., Kim, K.-P., Schöler, H. R., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc6983 · Cited by 45
Self-citationConklin, B., Conley, B. M., Hou, Y., Chen, M., & Lee, K.-B. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114636 · Cited by 45
Raabe, F. J., Galinski, S., Papiol, S., Falkai, P., Schmitt, A., & Rossner, M. J. (2018) · Schizophrenia · doi:10.1038/s41537-018-0066-4 · Cited by 48
Emerging Cellular and Molecular Strategies for Enhancing Central Nervous System (CNS) Remyelination
Abu-Rub, M., & Miller, R. H. (2018) · Brain Sciences · doi:10.3390/brainsci8060111 · Cited by 46
Namchaiw, P., Han, W., Mayrhofer, F., Chechneva, O. V., Biswas, S., & Deng, W. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1374-y · Cited by 42
Species differences in immune‐mediated CNS tissue injury and repair: A (neuro)inflammatory topic
Healy, L. M., Yaqubi, M., Ludwin, S. K., & Antel, J. P. (2019) · Glia · doi:10.1002/glia.23746 · Cited by 41
Self-citationMechanisms and repair strategies for white matter degeneration in CNS injury and diseases
Shahsavani, N., Kataria, H., & Karimi‐Abdolrezaee, S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166117 · Cited by 43
Remyelination in the central nervous system
Franklin, R. J. M., Bodini, B., & Goldman, S. A. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041371 · Cited by 40
Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine
Summers, R. A., Fagiani, F., Rowitch, D. H., Absinta, M., & Reich, D. S. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.08.004 · Cited by 39
Fagiani, F., Pedrini, E., Taverna, S., Brambilla, E., Murtaj, V., Podini, P., Ruffini, F., Butti, E., Braccia, C., Andolfo, A., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101680 · Cited by 45
Self-citationChanoumidou, K., Hernández-Rodríguez, B., Windener, F., Thomas, C., Stehling, M., Mozafari, S., Albrecht, S., Ottoboni, L., Antel, J., Kim, K.-P., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.03.001 · Cited by 39
Self-citationUtilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia
Albert, K., Niskanen, J., Kälvälä, S., & Lehtonen, Š. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094334 · Cited by 40
Xu, J., Zhao, J., Wang, R., Zhang, Y., Shen, L., Xiao, Q., Xie, Y., Jiang, J., Nie, Y., & Deng, W. (2022) · Theranostics · doi:10.7150/thno.69217 · Cited by 40
Modelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells
Rowland, H. A., Hooper, N. M., & Kellett, K. A. B. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2663-z · Cited by 38
Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications
Essayan-Perez, S., Zhou, B., Nabet, A. M., Wernig, M., & Huang, Y. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104503 · Cited by 40
Windener, F., Grewing, L., Thomas, C., Dorion, M., Otteken, M., Kular, L., Jagodic, M., Antel, J. P., Albrecht, S., & Kuhlmann, T. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02733-x · Cited by 36
Self-citationThe application of in vitro ‐derived human neurons in neurodegenerative disease modeling
D’Souza, G. X., Rose, S. E., Knupp, A., Nicholson, D. A., Keene, C. D., & Young, J. E. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24615 · Cited by 36
García‐León, J. A., Cáceres-Palomo, L., Sánchez‐Mejías, E., Mejias‐Ortega, M., Nuñez‐Diaz, C., Fernandez-Valenzuela, J. J., Sanchez-Varo, R. M., Dávila, J. C., Vitórica, J., & Gutiérrez, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186867 · Cited by 35
Marangon, D., Caporale, N., Boccazzi, M., Abbracchio, M. P., Testa, G., & Lecca, D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.748849 · Cited by 34
Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?
Salado-Manzano, C., Perpiñá, U., Straccia, M., Molina-Ruiz, F. J., Cozzi, E., Rosser, A., & Canals, J. M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00250 · Cited by 34
Generation of defined neural populations from pluripotent stem cells
McComish, S. F., & Caldwell, M. A. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0214 · Cited by 32
Growing Glia: Cultivating Human Stem Cell Models of Gliogenesis in Health and Disease
Lanjewar, S. N., & Sloan, S. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.649538 · Cited by 31
Literature review and appraisal on alternative neurotoxicity testing methods
Masjosthusmann, S., Barenys, M., El‐Gamal, M., Geerts, L., Gerosa, L., Gorreja, A., Kühne, B. A., Marchetti, N., Tigges, J., Viviani, B., et al. (2018) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2018.en-1410 · Cited by 31
Liu, Z., Chao, J., Wang, C., Sun, G., Roeth, D., Liu, W., Chen, X., Li, L., Tian, E., Feng, L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112841 · Cited by 30
CRISPR-edited human ES-derived oligodendrocyte progenitor cells improve remyelination in rodents
Wagstaff, L. J., Bestard-Cuche, N., Kaczmarek, M., Fidanza, A., McNeil, L., Franklin, R. J. M., & Williams, A. C. (2024) · Nature Communications · doi:10.1038/s41467-024-52444-w · Cited by 30
Hong, Y., Yang, Q., Song, H., & Ming, G. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01990-8 · Cited by 34
Ahlfors, J.-E. W., Azimi, A., El‐Ayoubi, R., Velumian, A. A., Vonderwalde, I., Boscher, C., Mihai, O., Mani, S., Samoilova, M., Khazaei, M., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1255-4 · Cited by 32
Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?
Rodríguez-Jiménez, F. J., Ureña‐Peralta, J. R., Jendelová, P., & Erceg, S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.01.006 · Cited by 33
Single Site Fluorination of the GM4 Ganglioside Epitope Upregulates Oligodendrocyte Differentiation
Kieser, T. J., Santschi, N., Nowack, L., Kehr, G., Kuhlmann, T., Albrecht, S., & Gilmour, R. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00002 · Cited by 30
Self-citationEmerging cellular themes in leukodystrophies
Nowacki, J. C., Fields, A. M., & Fu, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.902261 · Cited by 29
Esmonde-White, C., Yaqubi, M., Bilodeau, P., Cui, Q., Pernin, F., Larochelle, C., Ghadiri, M., Xu, Y. K. T., Kennedy, T. E., Hall, J. A., et al. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz026 · Cited by 29
Self-citationGarcía‐León, J. A., Vitórica, J., & Gutiérrez, A. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0520 · Cited by 30
MacDougall, G., Brown, L. Y., Kantor, B., & Chiba‐Falek, O. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.01.001 · Cited by 31
Modeling Neurological Disorders in 3D Organoids Using Human-Derived Pluripotent Stem Cells
Bose, R., Banerjee, S., & Dunbar, G. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.640212 · Cited by 30
Human Oligodendrocytes and Myelin In Vitro to Evaluate Developmental Neurotoxicity
Chesnut, M., Härtung, T., Högberg, H. T., & Pamies, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157929 · Cited by 30
Falkai, P., Rossner, M. J., Raabe, F. J., Wagner, E. M., Keeser, D., Maurus, I., Roell, L., Chang, E., Seitz‐Holland, J., Schulze, T. G., et al. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad065 · Cited by 30
Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells
Naphade, S. B., Tshilenge, K., & Ellerby, L. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00810-8 · Cited by 30
Speicher, A. M., Korn, L., Csatári, J., Gonzalez-Cano, L., Heming, M., Thomas, C., Schroeter, C. B., Schafflick, D., Li, X., Gola, L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123476119 · Cited by 28
Self-citationMechanical regulation of oligodendrocyte biology
Makhija, E., Espinosa-Hoyos, D., Jagielska, A., & Vliet, K. J. V. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134673 · Cited by 27
Marei, H. E. S., Khan, M. U. A., & Hasan, A. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00504-2 · Cited by 27
Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS
Gerhards, R., Pfeffer, L. K., Lorenz, J., Starost, L. J., Nowack, L., Thaler, F., Schlüter, M., Rübsamen, H., Macrini, C., Winklmeier, S., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01086-2 · Cited by 26
Self-citationCui, Q., Lin, Y. H., Xu, Y. K. T., Fernandes, M. G. F., Rao, V. T. S., Kennedy, T. E., & Antel, J. P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233859 · Cited by 25
Self-citationSKAP2 as a new regulator of oligodendroglial migration and myelin sheath formation
Ghelman, J., Grewing, L., Windener, F., Albrecht, S., Zarbock, A., & Kuhlmann, T. (2021) · Glia · doi:10.1002/glia.24066 · Cited by 25
Self-citationBreedam, E. V., & Ponsaerts, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137140 · Cited by 26
Dooves, S., Leferink, P. S., Krabbenborg, S., Breeuwsma, N., Bots, S., Hillen, A. E. J., Jacobs, G., van der Knaap, M. S., & Heine, V. M. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.018 · Cited by 24
Qu, W., Canoll, P., & Hargus, G. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2022.05.006 · Cited by 24
Self-citationImmunology of oligodendrocyte precursor cells in vivo and in vitro
Antel, J. P., Lin, Y. H., Cui, Q., Pernin, F., Kennedy, T. E., Ludwin, S. K., & Healy, L. M. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.006 · Cited by 23
Self-citationInhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination
Galloway, D. A., Gowing, E., Setayeshgar, S., & Kothary, R. (2019) · Glia · doi:10.1002/glia.23711 · Cited by 23
The contribution of GTF2I haploinsufficiency to Williams syndrome
Chailangkarn, T., Noree, C., & Muotri, A. R. (2018) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2017.12.005 · Cited by 22
Applying hiPSCs and Biomaterials Towards an Understanding and Treatment of Traumatic Brain Injury
Lacalle‐Aurioles, M., de Camps, C. C., Zorca, C. E., Beitel, L. K., & Durcan, T. M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.594304 · Cited by 21
The multifaceted role of LRRK2 in Parkinson's disease: From human iPSC to organoids
Oun, A., Sabogal-Guáqueta, A. M., Galuh, S., Alexander, A., Kortholt, A., & Dolga, A. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105837 · Cited by 23
McCaughey‐Chapman, A., & Connor, B. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25173 · Cited by 21
Liang, S., Yin, N., & Faiola, F. (2019) · Stem Cells and Development · doi:10.1089/scd.2019.0007 · Cited by 21
Integrating CRISPR Engineering and hiPSC-Derived 2D Disease Modeling Systems
Rehbach, K., Fernando, M. B., & Brennand, K. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0518-19.2019 · Cited by 22
POLR3-Related Leukodystrophy: Exploring Potential Therapeutic Approaches
Perrier, S., Michell‐Robinson, M. A., & Bernard, G. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.631802 · Cited by 23
Marro, B. S., Skinner, D. D., Cheng, Y., Grist, J. J., Dickey, L. L., Eckman, E., Stone, C., Liu, L., Ransohoff, R. M., & Lane, T. E. (2019) · Journal of Virology · doi:10.1128/jvi.00240-19 · Cited by 20
Neural In Vitro Models for Studying Substances Acting on the Central Nervous System
Fritsche, E., Tigges, J., Hartmann, J., Kapr, J., Serafini, M. M., & Viviani, B. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_367 · Cited by 21
Zheng, C., Hervé, B., Meijer, M., Kirby, L. A., Guerreiro‐Cacais, A. O., Kukanja, P., Kabbe, M., Jimenez-Beristain, T., Olsson, T. P., Agirre, E., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02100-3 · Cited by 20
Guerreiro, S. R., & Maciel, P. (2023) · Cells · doi:10.3390/cells12040538 · Cited by 20
Prytkova, I., & Brennand, K. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00360 · Cited by 20
Induction of immunological tolerance to myelinogenic glial-restricted progenitor allografts
Li, S., Oh, B. C., Chu, C., Arnold, A., Jabłońska, A., Furtmüller, G. J., Qin, H., Boltze, J., Magnus, T. U., Ludewig, P., et al. (2019) · Brain · doi:10.1093/brain/awz275 · Cited by 19
Metadata
- Authors
- Ehrlich, M., Mozafari, S., Glatza, M., Starost, L., Velychko, S., Hallmann, A.-L., Cui, Q.-L., Schambach, A., Kim, K.-P., Bachelin, C., Marteyn, A., Hargus, G., Johnson, R. M., Antel, J., Sterneckert, J., Zaehres, H., Schöler, H. R., Baron-Van Evercooren, A., & Kuhlmann, T.
- Affiliations
- University Hospital Münster (DE)
- Centre National de la Recherche Scientifique (FR)
- Max Planck Institute for Molecular Biomedicine (DE)
- Montreal Neurological Institute and Hospital (CA)
- Medizinische Hochschule Hannover (DE)
- McGill University (CA)
- Center for Regenerative Therapies Dresden (DE)
- University of Münster (DE)
- INSERM, U1127, F-75013 Paris, France;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-02-28
- Volume
- 114
- Issue
- 11
- Pages
- E2243-E2252
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5358375
- OpenAlex
- W2592644893
- Cited by
- 257
- References
- 51
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 26 · 2023: 25 · 2022: 39 · 2021: 28 · 2020: 35 · 2019: 31 · 2018: 19 · 2017: 5
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-11-INBS-0011)
- National Institute of Neurological Disorders and Stroke (R25NS070697)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- oligodendrocyte differentiation, induced pluripotent stem cells, transcription factors, SOX10, Olig2, NKX6-2, myelination, myelin diseases, demyelination, neural progenitor cells, disease modeling, drug discovery screening
- MeSH terms
- Ectopic Gene Expression, Animals, Brain, Cell Differentiation, Cells, Cultured, Demyelinating Diseases, Disease Models, Animal, Myelin Basic Protein, Humans, Mutation, Myelin Sheath, Oligodendroglia, Spinal Cord, Transcription Factors, Biomarkers, Cluster Analysis, tau Proteins, Cell Death, Oxidative Stress, Cell Lineage, Gene Expression Profiling, Mice, Induced Pluripotent Stem Cells, Neural Stem Cells, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
